Successful treatment of cisplatin-induced hemolytic uremic syndrome with therapeutic plasma exchange

American Journal of Kidney Diseases

Volumn 32, Issue 2, 1998, Pages 314-317

  Palmisano, Joseph ^a   Agraharkar, Mahendra ^b   Kaplan, Andre A ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NONE

Author keywords

Cisplatin chemotherapy; Hemolytic uremic syndrome (HUS); Plasmapheresis; Therapeutic plasma exchange (TPE); Thrombotic thrombocytopenic purpura (TTP)

Indexed keywords

CISPLATIN; FRESH FROZEN PLASMA;

AGED; ANURIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONFUSION; EDEMA; FATIGUE; FEMALE; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; PLASMAPHERESIS; SQUAMOUS CELL CARCINOMA; TACHYCARDIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TONGUE CARCINOMA;

EID: 0031928171     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v32.pm9708619     Document Type: Article

References (17)

1. Lohrmann HP, Adam W, Heymer B, Kubanek B: Microangiopathic hemolytic anemia in metastatic carcinoma: Report of eight cases. Ann Intern Med 79:368-375, 1973
2. Sack GH Jr, Levin J, Bell WR: Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic and therapeutic features. Medicine 56:1-37, 1977
3. Gordon LI, Kwaan HC: Cancer and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 34:140-147, 1997
4. Jackson AM, Rose BD, Graff LG, Jacobs JB, Schwartz JH, Strauss GM, Yang JPS, Rudnick MR, Elfenbein IB, Narins RG: Thrombotic angiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 101:41-44, 1994
5. Licciardello JTW, Moake JL, Rudy CK, Karp DD, Hong WK: Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296-300, 1985
6. Sheldon R, Slaughter D: A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer 58:1428-1436, 1986
7. Watson PR, Guthrie TH, Caruana RJ: Cisplatin-associated hemolytic uremic syndrome: Successful treatment with a staphylococcal protein A column. Cancer 64: 1400-1403, 1989
8. Hanna W, Crauss S, Regestor R, Murphey W: Renal disease after mitomycin C therapy. Cancer 48:2583-2588, 1981
9. Moake JL, Byrnes JJ: Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin North Am 10:485-497, 1996
10. Grace AA, Barradas MA, Mikhailidis DP, Jeremy JY, Moorhead JF, Sweny P, Dandona P: Cyclosporin A enhances platelet aggregation. Kidney Int 32:889-895, 1987
11. Brown Z, Neild GH: Cyclosporin inhibits prostacyclin production by cultured human endothelial cells. Trans Proc 19:1178-1180, 1987
12. Charba D, Moake JL, Harris MA: Abnormalities of von Willebrand multimers in drug-associated thrombotic microangiopathies. Am J Hematol 42:268-277, 1993
13. DaSilva K, Pasquale D, Tsan MF, Chikkappa G: Cyclosporin A (CyA): An effective therapy for thrombotic thrombocytopenic purpura. Blood 82:411A, 1993 (abstr)
14. Gable PS, Smith WS, Millard FE: Cyclosporin in relapsed thrombotic thrombocytopenic purpura. Blood 82: 604A, 1993 (abstr)
15. Kierdorf H, Maureen M, Heinz B: Cyclosporin for thrombotic thrombocytopenic purpura. Ann Intern Med 4:210, 1993 (letter)
16. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, and the Canadian Apheresis Study Group: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393-397, 1991
17. Snyder HJ, Mittleman A, Oral A, Messerschmidt GL, Henry DH, Korec S, Bertram JH, Guthrie TH, Ciavarella D, Wuest D, Perkins W, Balint JP, Cochran SK, Peugeot RL, Jones FR: Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 71:1882-1892, 1993